Gsk Income Statement (2009-2026) | GSK

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	8.16B	9.14B	9.54B	9.65B	8.73B	9.23B	16.56B	8.45B	8.98B	10.32B	17.54B	9.34B	9.95B	10.41B	19.57B	9.47B	10.65B	11.53B	11.46B	10.29B
Cost of Revenue (Quarter)	2.39B	2.78B	11.00B	3.65B	2.74B	2.86B	11.21B	2.36B	2.42B	2.88B	10.63B	2.50B	2.68B	3.11B	11.61B	2.44B	2.89B	3.05B	11.99B	2.53B
Gross Profit (Quarter)	5.77B	6.36B	5.78B	6.00B	5.99B	6.37B	10.82B	6.09B	6.56B	7.44B	12.73B	6.84B	7.27B	7.30B	14.32B	7.03B	7.77B	8.49B	7.93B	7.76B
Operating items
Research & Development (Quarter)	-1.63B	-1.95B	-1.85B	-1.48B	-1.56B	-1.59B	-6.44B	-1.53B	-1.68B	-2.00B	-7.72B	-1.82B	-1.86B	-1.90B	-8.22B	-1.84B	-2.70B	-2.28B	-10.01B	-2.28B
Selling, General & Administrative (Quarter)	-2.36B	-2.31B	-9.53B	-2.43B	-2.60B	-2.42B	-9.82B	-2.60B	-2.84B	-2.91B	-11.65B	-2.65B	-3.11B	-4.94B	-14.14B	-2.61B	-2.85B	-3.02B	-12.09B	-2.86B
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)	-0.11B	-0.34B	-0.49B	0.80B	-0.66B	-1.26B	0.89B	0.36B	0.35B	-0.46B	-0.71B	-0.68B	-0.40B	-0.44B	-1.96B	-0.01B	0.16B	0.03B	-0.16B	0.21B
Operating Expenses (Quarter)	-3.99B	-4.27B	-11.39B	-3.91B	-4.17B	-4.01B	-16.26B	-4.14B	-4.52B	-4.90B	-19.37B	-4.47B	-4.98B	-6.83B	-22.35B	-4.45B	-5.55B	-5.30B	-22.10B	-5.14B
Operating Income (Quarter)	1.78B	1.90B	0.66B	3.08B	1.36B	1.40B	3.96B	2.53B	2.68B	2.47B	5.24B	1.89B	2.08B	0.25B	4.03B	2.79B	2.70B	3.50B	1.46B	3.09B
EBIT (Quarter)	1.78B	1.90B	0.66B	3.08B	1.36B	1.40B	3.96B	2.53B	2.68B	2.47B	5.24B	1.89B	2.08B	0.25B	4.03B	2.79B	2.70B	3.50B	1.46B	3.09B
Non-operating items
Interest & Investment Income (Quarter)	0.01B	0.01B		0.01B	0.03B	0.06B		0.04B	0.04B	0.11B		0.04B	0.03B	0.11B		0.07B	0.07B	0.18B		0.03B
Non Operating Income (Quarter)	-0.26B	-0.26B	-1.02B	0.27B		-0.05B	-0.92B	0.21B	-0.37B	-0.01B	-0.32B	0.17B	-0.31B	-0.02B	-0.26B	0.14B	-0.29B	-0.05B	-0.70B	0.20B
Net income details
EBT (Quarter)	1.50B	1.64B	4.85B	2.81B	1.13B	1.19B	3.51B	2.32B	2.49B	2.27B	4.83B	1.72B	1.89B	0.08B	3.66B	2.66B	2.52B	3.31B	1.26B	2.89B
Tax Provisions (Quarter)	0.28B	-0.34B	0.16B	-0.43B	-0.19B	-0.27B	-0.83B	-0.34B	-0.30B	-0.33B	-0.94B	-0.35B	-0.24B	0.00B	-0.68B	-0.42B	-0.32B	-0.42B	-1.48B	-0.41B
Profit After Tax (Quarter)	1.78B	1.30B	0.57B	2.38B	0.94B	0.92B	2.95B	1.98B	2.18B	1.94B	4.19B	1.37B	2.13B	0.08B	3.06B	2.23B	2.84B	3.74B	0.97B	2.48B
Equity Income (Quarter)				-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B		-0.01B	-0.00B	-0.00B	-0.00B	-0.00B		-0.00B	0.01B	-0.00B	-0.01B
Net Income - Minority (Quarter)
Income from Non-Controlling Interests (Quarter)	0.08B	0.28B	0.24B	0.37B	0.05B	0.02B	0.37B	1.98B	2.18B	1.94B	4.19B	1.37B	1.65B	0.08B	3.79B	2.23B	2.20B	2.89B	8.37B	2.48B
Income from Continuing Operations (Quarter)	1.21B	1.98B	4.69B	3.24B	1.32B	1.47B	4.34B	2.65B	2.79B	2.59B	5.77B	2.07B	2.13B	0.08B	4.33B	3.08B	2.84B	3.74B	2.74B	3.30B
Consolidated Net Income (Quarter)	0.37B	0.58B	2.13B	0.53B	0.29B	11.88B	0.73B	2.65B	2.79B	2.59B	5.77B	2.07B	2.13B	0.08B	4.33B	3.08B	2.84B	3.74B	2.74B	3.30B
Income towards Parent Company (Quarter)	1.95B	1.61B	1.01B	2.42B	1.06B	12.75B	17.54B	1.81B	2.03B	1.85B	3.86B	1.33B	1.48B	-0.08B	2.85B	2.05B	1.93B	2.72B	0.85B	2.34B
Net Income towards Common Stockholders (Quarter)	1.95B	1.61B	1.01B	2.42B	1.06B	12.75B	17.54B	1.81B	2.03B	1.85B	3.86B	1.33B	1.48B	-0.08B	2.85B	2.05B	1.93B	2.72B	0.85B	2.34B
Additional items
EPS (Basic) (Quarter)	0.00	0.00	0.19	0.00	0.00	0.00	3.71	0.00	0.00	0.00	0.77	0.00	0.00	0.00	1.65	0.00	0.00	0.00	0.00	0.00
EPS (Weighted Average and Diluted) (Quarter)	0.00B	0.00B	0.00B	0.00B		0.00B	-0.00B
Shares Outstanding (Weighted Average) (Quarter)	1,882,739.96B	1,856,951.77B	5.40B	1,807,452.69B	1,696,296.23B	1,587,504.55B	4.72B	4,915,520.50B	1,686,837.53B	1,707,491.10B	5.03B	1,709,962.51B	1,701,473.57B	1,751,456.62B	1.73B	1,699,066.23B	1,799,627.63B	1,820,289.54B	1,794,394.20B	1,818,692.66B
Shares Outstanding (Diluted Average) (Quarter)
EBITDA (Quarter)	1.78B	1.90B	0.66B	3.08B	1.36B	1.40B	3.96B	2.53B	2.68B	2.47B	5.24B	1.89B	2.08B	0.25B	4.03B	2.79B	2.70B	3.50B	1.46B	3.09B
Interest Expenses (Quarter)	-0.26B	-0.27B	-1.04B	-0.28B	-0.26B	-0.24B	-1.03B	-0.25B	-0.23B	-0.23B	-0.98B	-0.21B	-0.22B	-0.20B	-0.86B	-0.20B	-0.25B	-0.23B	-0.93B	-0.23B
Tax Rate (Quarter)	18.79%	-20.64%	3.25%	-15.43%	-16.74%	-23.02%	-23.65%	-14.47%	-12.18%	-14.35%	-19.41%	-20.22%	-12.78%	1.56%	-18.46%	-15.94%	-12.77%	-12.70%	-117.05%	-14.23%

Research Tools

Developers

Gsk Income Statement (2009-2026) | GSK

Research Tools

Developers

Gsk Income Statement (2009-2026) | GSK

Create an account

Sign In

Reset Password